Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. (DNPUF) Shares Outstanding — Overview
Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.
DNPUF · shares outstanding · updated Jun 9, 2026
Key metrics
as of Mar 31, 2026Shares Outstanding Growth Rate
CAGR · weighted avg basic sharesNegative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials
Shares outstanding history
Annual shares outstanding by year
Healthcare sector shares outstanding comparison
Shares Outstanding for similar companies or competitors in the Healthcare sector.
MRK
JNJ
ABBV
AZN
UNH
LLYDNPUF/company-screener · per-peer /income-statement · cache 86400s
Understanding Shares Outstanding
Basic · Diluted · FloatWhat Are Shares Outstanding? (Basic)
Sumitomo Pharma Co., Ltd. (DNPUF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2026, Sumitomo Pharma Co., Ltd. reports 397.3M basic shares outstanding (weighted average).
Basic vs. Diluted Shares Outstanding
Sumitomo Pharma Co., Ltd.'s basic shares outstanding (397.3M) represents currently issued shares. Diluted shares outstanding (397.3M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.
Shares Outstanding vs. Float (Free Float)
Sumitomo Pharma Co., Ltd.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.
ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.
FMP /income-statement · /shares-float · SEC EDGAR · JPY
About shares outstanding & methodology
Sumitomo Pharma Co., Ltd. (DNPUF) shares outstanding history from 2007 to 2026. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.
Sumitomo Pharma Co., Ltd. shares outstanding for the fiscal year ending March 31, 2026 were 397.3M, a 0.00% increase year-over-year. Sumitomo Pharma Co., Ltd. FY 2026 shares outstanding were 397.3M, a +0.00% increase from FY 2025.
Sumitomo Pharma Co., Ltd. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +0.0% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.
Frequently asked questions
DNPUF shares outstanding · 4 questionsAs of March 31, 2026, Sumitomo Pharma Co., Ltd. (DNPUF) has approximately 397.3M basic shares outstanding and 397.3M diluted shares outstanding. This represents a +0.00% year-over-year increase from FY 2025 (397.3M). The increase may reflect equity compensation issuances or secondary offerings.
▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Sumitomo Pharma Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09